Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Morgan Stanley raised the price target for Robinhood Markets Inc (NASDAQ:HOOD) from $150 to $160. Morgan Stanley analyst Michael Cyprys maintained an Overweight rating. Robinhood shares closed at $107.01 on Thursday. See how other analysts view this stock.
- Rosenblatt cut Webull Corp (NASDAQ:BULL) price target from $15 to $12. Rosenblatt analyst Chris Brendler maintained a Buy rating. Webull shares closed at $5.95 on Thursday. See how other analysts view this stock.
- Stifel slashed price target for Align Technology Inc (NASDAQ:ALGN) from $210 to $175. Stifel analyst Jonathan Block maintained a Buy rating. Align Technology shares closed at $141.03 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. cut the price target for Pacira Biosciences Inc (NASDAQ:PCRX) from $38 to $36.5. HC Wainwright & Co. analyst Douglas Tsao downgraded the stock from Buy to Neutral. Pacira Biosciences shares closed at $36.39 on Thursday. See how other analysts view this stock.
- Cantor Fitzgerald raised Sailpoint Inc (NASDAQ:SAIL) price target from $25 to $27. Cantor Fitzgerald analyst Jonathan Ruykhaver maintained an Overweight rating. Sailpoint shares closed at $20.02 on Thursday. See how other analysts view this stock.
- BTIG boosted Unity Software Inc (NYSE:U) price target from $51 to $53. BTIG analyst Clark Lampen maintained a Buy rating. Unity Software shares closed at $45.89 on Thursday. See how other analysts view this stock.
- Needham raised CrowdStrike Holdings Inc (NASDAQ:CRWD) price target from $250 to $310. Needham analyst Mike Cikos maintained a Buy rating. Crowdstrike shares closed at $263.01 on Thursday. See how other analysts view this stock.
- Baird increased the price target for Humana Inc (NYSE:HUM) from $390 to $596. Baird analyst Michael Ha upgraded the stock from Neutral to Outperform. Humana shares closed at $387.12 on Thursday. See how other analysts view this stock.
- Leerink Partners increased Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) price target from $13 to $19. Leerink Partners analyst Lili Nsongo maintained an Outperform rating. Arcturus Therapeutics shares closed at $12.87 on Thursday. See how other analysts view this stock.
- Scotiabank cut AT&T Inc (NYSE:T) price target from $27.5 to $26.5. Scotiabank analyst Maher Yaghi maintained a Sector Perform rating. AT&T shares closed at $24.59 on Friday. See how other analysts view this stock.
Considering buying CRWD stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment